New combo aims to ease pain in newborn surgery
NCT ID NCT07609836
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding dexamethasone to the standard painkiller bupivacaine improves pain relief for newborns undergoing inguinal hernia repair. 150 full-term infants will be randomly assigned to receive either the combination or bupivacaine alone via a caudal injection. Pain will be measured using the FLACC scale for 24 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dexamethasone added to bupivacaine
- What this could lead to
- If it works, this could provide better pain control for newborns after hernia surgery, reducing their discomfort.
- What could go wrong
- This is a small, early-stage study with no phase assigned. The added dexamethasone may not improve pain relief and could carry risks like infection or delayed healing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
1 day to 28 days
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * full term neonate * ASA I \& ASA II * Scheduled for inguinal hernia repair Exclusion Criteria: * Patients with allergies to studied drugs * body weight \<3 kilograms * parents refusal
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for We are studying the effects of caudal dexamethasone in neonates undergoing inguinal hernia repair are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.